Mirvie
PrivateLast Round
Series C
Sep 11, 2025
Est. Valuation
$155M
Total Funding Raised
$124.6M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Mirvie operates in Healthcare & Life Sciences and is based in South San Francisco, California. Its latest recorded funding round was a Series C round in August 2025.
Mirvie is a biotechnology company that provides a medical diagnostic platform aimed at enhancing pregnancy safety through predictive tests and therapeutic solutions for effective pregnancy management.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Medical Devices, Clinical Trials
Business Model
B2B2C
Customer Profile
Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mirvie Comparables
Compare Mirvie with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sera Prognostics Inc. | 77% | |
| Trinity Biotech plc | 77% | |
| NX Prenatal Inc. | 76% |
For institutional investors. Book with your work email.
Mirvie Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Sep 11, 2025 | ||||
| Series C | Aug 1, 2025 | ||||
| Grant | Aug 2, 2023 | ||||
| Debt | May 17, 2022 | ||||
| Series B | May 17, 2022 | ||||
Series A | Apr 27, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Mirvie Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| GV | Series B |
| Khosla Ventures | Series B, Series A |
| Portfolia | Series C |
| Gates Foundation | Grant |
| General Catalyst | Series B |
| Foresite Capital | Series B |
| The Bill & Melinda Gates Foundation Trust | Grant |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 28, 2026
Monthly visitors increased 31% MoM, reaching 4.7K.
- Sep 11, 2025
Raised $30M in Series C funding.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- promotesNov 10, 2026
Mirvie, Inc. transitions co-founder Maneesh Jain, PhD, from CEO to Executive Vice Chair of the Board as he passes leadership to David to accelerate and scale commercial growth.
- hiresNov 10, 2026
Mirvie, Inc. hires David Stern as Chief Executive Officer, bringing more than 30 years of women’s health leadership to the pregnancy health company on Nov. 10th '26.
For institutional investors. Book with your work email.
Mirvie Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Mirvie's valuation, stock price, and market status.
Is Mirvie a public or private company?
Mirvie is a private company.
What is the current stock price of Mirvie?
Mirvie is a private company, so its shares have no public market price. Caplight tracks Mirvie's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Mirvie worth (valuation)?
Mirvie's valuation is estimated at $155.0M based on funding round data.
Can I buy Mirvie stock?
Mirvie shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Mirvie's last funding round?
Mirvie's most recent funding round was Series C on September 11, 2025.
Who are the main investors in Mirvie?
Key investors in Mirvie include Khosla Ventures, Decheng Capital, Mayfield Fund.
Will Mirvie IPO soon?
No public IPO plans have been announced for Mirvie.
How can I track Mirvie secondary market activity?
Caplight tracks bids, offers, and trades in Mirvie's shares on secondary markets.